NOS3 and hypertensive disorder: The activation of TLR4 further stimulates nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, increasing reactive oxygen species (ROS) production, which in turn inhibits endothelial nitric oxide synthase (eNOS) activity, thereby contributing to endothelial dysfunction, vascular inflammation, and hypertension.